ReviewCureus2026

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Conditions Beyond Heart Failure and Chronic Kidney Disease: Emerging Evidence, Mechanisms, and Practical Considerations.

Digantkumar Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.